{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:30:54Z","timestamp":1791156654591,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.2515\/therapie\/2012039","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T09:38:42Z","timestamp":1351676322000},"page":"277-281","source":"Crossref","is-referenced-by-count":4,"title":["Le parac\u00e9tamol : un anc\u00eatre plein d\u2019avenir"],"prefix":"10.1016","volume":"67","author":[{"given":"Christophe","family":"Mallet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Barri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Eschalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2012039_bb0005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0165-6147(00)01502-9","article-title":"NK1 (substance P) receptor antagonists--why are they not analgesic in humans?","volume":"21","author":"Hill","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.2515\/therapie\/2012039_bb0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/240410a0","article-title":"Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol)","volume":"240","author":"Flower","year":"1972","journal-title":"Nature"},{"key":"10.2515\/therapie\/2012039_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2006.03.061","article-title":"The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice","volume":"538","author":"Ayoub","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.2515\/therapie\/2012039_bb0020","series-title":"Pharmacology of Pain","first-page":"65","article-title":"Pharmacology and Mechanism of Action of Acetaminophen","author":"Mallet","year":"2010"},{"key":"10.2515\/therapie\/2012039_bb0025","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1096\/fj.03-0595lte","article-title":"COX-3--a virtual pain target in humans?","volume":"17","author":"Schwab","year":"2003","journal-title":"Faseb J"},{"key":"10.2515\/therapie\/2012039_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-2478(02)00268-7","article-title":"COX-3: in the wrong frame in mind","volume":"86","author":"Dinchuk","year":"2003","journal-title":"Immunol Lett"},{"key":"10.2515\/therapie\/2012039_bb0035","first-page":"5(9)","article-title":"TRPV1 in brain is involved in acetaminophen-induced antinociception","volume":"17","author":"Mallet","year":"2010","journal-title":"PLoS One"},{"key":"10.2515\/therapie\/2012039_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(91)90036-P","article-title":"Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems","volume":"193","author":"Tjolsen","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.2515\/therapie\/2012039_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-2999(96)00261-0","article-title":"The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain","volume":"308","author":"Pini","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.2515\/therapie\/2012039_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(02)01578-9","article-title":"Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats","volume":"443","author":"Alloui","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.2515\/therapie\/2012039_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(25)20101-X","article-title":"Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence","volume":"278","author":"Pelissier","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.2515\/therapie\/2012039_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(01)01464-9","article-title":"5-HT receptor subtypes involved in the spinal antinociceptive effect of acetaminophen in rats","volume":"432","author":"Courade","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.2515\/therapie\/2012039_bb0065","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-3565(24)36432-8","article-title":"Naloxone-reversible antinociception by paracetamol in the rat","volume":"280","author":"Pini","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.2515\/therapie\/2012039_bb0070","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s002100100484","article-title":"Effects of acetaminophen on monoaminergic systems in the rat central nervous system","volume":"364","author":"Courade","year":"2001","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.2515\/therapie\/2012039_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.clpt.6100403","article-title":"Acetaminophen reinforces descending inhibitory pain pathways","volume":"84","author":"Pickering","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.2515\/therapie\/2012039_bb0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.clpt.2005.12.307","article-title":"Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism","volume":"79","author":"Pickering","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.2515\/therapie\/2012039_bb0085","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.pain.2011.02.003","article-title":"Tropisetron blocks analgesic action of acetaminophen: A human pain model study","volume":"152","author":"Bandschapp","year":"2011","journal-title":"Pain"},{"key":"10.2515\/therapie\/2012039_bb0090","doi-asserted-by":"crossref","first-page":"31405","DOI":"10.1074\/jbc.M501489200","article-title":"Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolasedependent arachidonic acid conjugation in the nervous system","volume":"280","author":"H\u00f6gest\u00e4tt","year":"2005","journal-title":"J Biol Chem"},{"key":"10.2515\/therapie\/2012039_bb0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pain.2008.03.030","article-title":"Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia","volume":"139","author":"Mallet","year":"2008","journal-title":"Pain"},{"key":"10.2515\/therapie\/2012039_bb0100","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/nbdi.1998.0214","article-title":"Biochemistry of the endogenous ligands of cannabinoid receptors","volume":"5","author":"Di Marzo","year":"1998","journal-title":"Neurobiol Dis"},{"key":"10.2515\/therapie\/2012039_bb0105","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1073\/pnas.0730816100","article-title":"Evidence against the presence of an anandamide transporter","volume":"100","author":"Glaser","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.2515\/therapie\/2012039_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(24)29345-9","article-title":"Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology","volume":"298","author":"Giuffrida","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.2515\/therapie\/2012039_bb0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejphar.2005.12.015","article-title":"The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors","volume":"531","author":"Ottani","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.2515\/therapie\/2012039_bb0120","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.neuropharm.2009.12.010","article-title":"Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain","volume":"58","author":"Hama","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.2515\/therapie\/2012039_bb0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"10.2515\/therapie\/2012039_bb0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrd2280","article-title":"The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept","volume":"6","author":"Szallasi","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.2515\/therapie\/2012039_bb0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2008.01.024","article-title":"Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans","volume":"136","author":"Gavva","year":"2008","journal-title":"Pain"},{"key":"10.2515\/therapie\/2012039_bb0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/pr.109.001263","article-title":"The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not","volume":"61","author":"Romanovsky","year":"2009","journal-title":"Pharmacol Rev"},{"key":"10.2515\/therapie\/2012039_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00207-7","article-title":"The anandamide transport inhibitor AM404 activates vanilloid receptors","volume":"396","author":"Zygmunt","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.2515\/therapie\/2012039_bb0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1744-8069-2-34","article-title":"Hot receptors in the brain","volume":"2","author":"Steenland","year":"2006","journal-title":"Mol Pain"},{"key":"10.2515\/therapie\/2012039_bb0155","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.mce.2008.01.013","article-title":"Role of TRPV1 receptors in descending modulation of pain","volume":"286","author":"Palazzo","year":"2008","journal-title":"Mol Cell Endocrinol"},{"issue":"1-3","key":"10.2515\/therapie\/2012039_bb0160","first-page":"93","article-title":"Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT(7) receptors","volume":"677","author":"Dogrul","year":"2011","journal-title":"Eur J Pharmacol 2012 Feb 29"},{"key":"10.2515\/therapie\/2012039_bb0165","first-page":"551","article-title":"TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid (9)-tetra-hydrocannabiorcol","volume":"2","author":"Andersson","year":"2011","journal-title":"Nat Commun 2011 Nov 22"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716308496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716308496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:31:37Z","timestamp":1745109097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716308496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0040595716308496"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2012039","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}